Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly's weight-loss drug Zepbound is going swimmingly in the U.S., Jefferies said Friday.
Eli Lilly's office in La Jolla, California.
Konrad Fiedler | Bloomberg | Getty Images
The launch of Eli Lilly's weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday.